BNP/PUT/ELI LILLY & CO/850/0.1/21.03.25 | Market Closed - Boerse Frankfurt Warrants 15:50:31 2024-07-03 EDT | ||
| 6.04 EUR | +5.41% |
|
| Current month | +9.19% | ||
| 1 month | -27.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 6.06 | +5.76% |
| 24-07-02 | 5.73 | +5.33% |
| 24-07-01 | 5.44 | -1.98% |
| 24-06-28 | 5.55 | -0.89% |
| 24-06-27 | 5.6 | -3.95% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 03:50 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PC9XJD |
| ISIN | DE000PC9XJD6 |
| Date issued | 2024-05-15 |
| Strike | 850 $ |
| Maturity | 2025-03-21 (261 Days) |
| Parity | 10 : 1 |
| Emission price | 10.19 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.65 € |
|---|---|
| Lowest since issue | 5.3 € |
| Delta | -0.33x |
| Omega | 4.571 |
| Premium | 12.68x |
| Gearing | 13.66x |
| Moneyness | 0.9464 |
| Difference Strike | -48.1 $ |
| Difference Strike % | -5.66% |
| Spread | 0.11 € |
| Spread % | 1.79% |
| Theoretical value | 6.095 |
| Implied Volatility | 33.80 % |
| Total Loss Probability | 56.85 % |
| Intrinsic value | 0.000000 |
| Present value | 6.095 |
| Break even | 784.25 € |
| Theta | -0.09x |
| Vega | 0.25x |
| Rho | -0.18x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Warrants
- Warrant
